BioCentury
ARTICLE | Financial News

Anti-infective play Iterum debuts with $40M

March 25, 2016 12:45 AM UTC

Iterum Therapeutics Ltd. (Dublin, Ireland) raised $40 million in a series A round led by Frazier Healthcare Partners. Canaan Partners, Sofinnova Ventures and New Leaf Venture Partners also participated. The newco also licensed an undisclosed anti-infective compound from an undisclosed pharma.

Iterum said the anti-infective has shown in vitro activity against Gram-negative, Gram-positive and anaerobic bacteria resistant to other antibiotics. CEO Corey Fishman told BioCentury the compound "has had some previous work done in the clinic." ...